Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Revenue (Annual): 1.697B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.697B |
| December 31, 2022 | 1.305B |
| December 31, 2021 | 1.099B |
| December 31, 2020 | 904.40M |
| December 31, 2019 | 738.20M |
| December 31, 2018 | 563.80M |
| December 31, 2017 | 463.80M |
| December 31, 2016 | 366.99M |
| December 31, 2015 | 263.89M |
| December 31, 2014 | 231.32M |
| Date | Value |
|---|---|
| December 31, 2013 | 247.08M |
| December 31, 2012 | 211.37M |
| December 31, 2011 | 152.26M |
| December 31, 2010 | 96.97M |
| December 31, 2009 | 66.03M |
| December 31, 2008 | 36.06M |
| December 31, 2007 | 13.37M |
| December 31, 2006 | 3.663M |
| December 31, 2005 | 0.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
738.20M
Minimum
2019
1.697B
Maximum
2023
1.149B
Average
1.099B
Median
2021
Revenue (Annual) Benchmarks
| Abbott Laboratories | 40.11B |
| Stryker Corp | 20.50B |
| Tandem Diabetes Care Inc | 747.72M |
| Becton Dickinson & Co | 19.37B |
| ResMed Inc | 4.223B |